ScholarGate
Asystent

Pituitary Adenoma

Pituitary adenomas are benign tumors of the anterior pituitary gland, now widely termed pituitary neuroendocrine tumors. They produce clinical effects in two ways: by secreting excess hormone (functioning adenomas) and by enlarging within the sella to compress neighboring structures such as the optic chiasm (mass effect of nonfunctioning adenomas).

Znajdź temat z PaperMindWkrótceFind papers & topics
Tools & resources
Pobierz slajdy
Learn & explore
WideoWkrótce

Definition

A pituitary adenoma is a benign neoplasm arising from the hormone-producing cells of the anterior pituitary (adenohypophysis); it is classified as functioning or nonfunctioning by hormone secretion and as a microadenoma or macroadenoma by size, and is increasingly designated a pituitary neuroendocrine tumor.

Scope

The entry covers pituitary adenoma as a tumor entity at the interface of neurosurgery and endocrinology: the distinction between functioning and nonfunctioning tumors, micro- versus macroadenomas, the mass-effect syndromes from sellar and suprasellar growth, and how classification has shifted toward a neuroendocrine framework. It is a reference description, not clinical guidance.

Core questions

  • How do functioning and nonfunctioning adenomas differ in how they present?
  • Why does suprasellar extension threaten vision through the optic chiasm?
  • What distinguishes a microadenoma from a macroadenoma and why does it matter?
  • How has classification shifted toward the pituitary neuroendocrine tumor concept?

Key concepts

  • Functioning versus nonfunctioning adenoma
  • Microadenoma versus macroadenoma
  • Hormone hypersecretion syndromes
  • Sellar and suprasellar mass effect
  • Optic chiasm compression and bitemporal hemianopia
  • Pituitary neuroendocrine tumor (PitNET) concept
  • Pituitary apoplexy

Mechanisms

Pituitary adenomas arise from clonal expansion of adenohypophyseal cells. Functioning tumors secrete a pituitary hormone autonomously, producing recognizable endocrine syndromes according to the hormone involved, whereas nonfunctioning tumors typically come to attention through mass effect. As an adenoma enlarges within the bony sella turcica and extends upward, it can compress the optic chiasm, classically causing a bitemporal visual field defect, and can impair surrounding normal pituitary function. Sudden hemorrhage or infarction of an adenoma, known as pituitary apoplexy, can cause an acute syndrome. The 2022 WHO classification reframes these tumors as pituitary neuroendocrine tumors defined by cell lineage and transcription factors.

Clinical relevance

Pituitary adenoma is a model of a tumor whose clinical picture depends jointly on its hormonal activity and its anatomical relationships, bridging neurosurgical and endocrine reasoning. This entry describes the entity and its classification for educational orientation and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Pituitary adenomas are common, and small nonfunctioning tumors are frequently discovered incidentally on imaging. Clinically relevant adenomas account for a substantial share of intracranial tumors, with the relative frequency of hormone-secreting subtypes varying by population and detection patterns.

Evidence & guidelines

Narrative reviews such as Melmed's synthesize the endocrinology and mass effects of pituitary tumors, the 2022 WHO classification provides the pituitary neuroendocrine tumor framework, and Congress of Neurological Surgeons guidelines address evaluation and follow-up of nonfunctioning adenomas.

History

Surgical access to the pituitary through the transsphenoidal route was pioneered in the early twentieth century by Harvey Cushing and others, and Cushing's description of pituitary basophilism linked an adenoma to an endocrine syndrome. Classification evolved from hormone-staining categories toward the cell-lineage and transcription-factor framework of the 2022 WHO classification, which adopted the pituitary neuroendocrine tumor terminology.

Debates

Should the term pituitary neuroendocrine tumor replace adenoma?
The 2022 WHO classification adopted pituitary neuroendocrine tumor terminology to reflect cell lineage and biological behavior, but whether and how widely this should supplant the long-established term adenoma has been actively discussed.
How should incidental nonfunctioning adenomas be followed?
Many small nonfunctioning tumors are found incidentally and remain stable, so the appropriate intensity and duration of surveillance versus intervention is a matter of evidence-based judgement.

Key figures

  • Shlomo Melmed
  • Sylvia L. Asa
  • Ozgur Mete

Related topics

Seminal works

  • melmed-2020
  • asa-2022
  • ziu-2016

Frequently asked questions

What is the difference between a functioning and a nonfunctioning pituitary adenoma?
A functioning adenoma secretes excess pituitary hormone and causes an endocrine syndrome, whereas a nonfunctioning adenoma does not secrete active hormone and usually becomes apparent through mass effect on nearby structures.
Why can a pituitary tumor affect vision?
As the tumor enlarges and extends above the sella, it can press on the optic chiasm directly overhead, classically producing loss of the outer (temporal) visual fields in both eyes.

Methods for this concept

Related concepts